These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6418181)

  • 21. [Ketoprofen lysine treatment of painful manifestations of spinal osteoarthrosis].
    Memeo A; Cosentina R
    Clin Ter; 1988 Jul; 126(2):119-22. PubMed ID: 2974377
    [No Abstract]   [Full Text] [Related]  

  • 22. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.
    Ishizaki T; Sasaki T; Suganuma T; Horai Y; Chiba K; Watanabe M; Asuke W; Hoshi H
    Eur J Clin Pharmacol; 1980 Nov; 18(5):407-14. PubMed ID: 7439263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and tolerability of ketoprofen lysine, once a day, in patients with rheumatic disorders.
    Chevallard M; Mele G; Borsa M; Malandrino S; Tonon GC; Carrabba M
    Drugs Exp Clin Res; 1987; 13(5):293-6. PubMed ID: 3119304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronokinetics of ketoprofen administered orally and by continuous venous infusion].
    Queneau P; Decousus H; Ollagnier M; Cherrah Y; Perpoint B; Hocquart J
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):403-8. PubMed ID: 4048810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate.
    Brazier JL; Tamisier JN; Ambert D; Bannier A
    Eur J Clin Pharmacol; 1981 Mar; 19(4):305-7. PubMed ID: 7286034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.
    Debruyne D; Hurault de Ligny B; Ryckelynck JP; Albessard F; Moulin M
    Clin Pharmacokinet; 1987 Mar; 12(3):214-21. PubMed ID: 3581635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of a new ketoprofen formulation for once-daily oral administration.
    Roda A; Sabatini L; Mirasoli M; Baraldini M; Roda E
    Int J Pharm; 2002 Jul; 241(1):165-72. PubMed ID: 12086732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a new topical gel-spray formulation of ketoprofen lysine salt in the rat: percutaneous permeation in vitro and in vivo and pharmacological activity.
    Porzio S; Caselli G; Pellegrini L; Pallottini V; Del Rosario M; Coppola A; Boltri L; Gentile M; Clavenna G; Melillo G
    Pharmacol Res; 1998 Jan; 37(1):41-7. PubMed ID: 9503479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Open clinical trial of a new oral galenic form of ketoprofen].
    Huck F; Lecocq J; Meyer R; Kuntz JL; Asch L
    Sem Hop; 1983 Dec; 59(46):3240-2. PubMed ID: 6318350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ketoprofen in the elderly.
    Advenier C; Roux A; Gobert C; Massias P; Varoquaux O; Flouvat B
    Br J Clin Pharmacol; 1983 Jul; 16(1):65-70. PubMed ID: 6882624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis.
    McCrea JD; Telford AM; Kaye CM; Boyd MW
    Curr Med Res Opin; 1986; 10(2):73-81. PubMed ID: 3519094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G; Larsen HW; Hansen H; Sørensen
    Scand J Rheumatol; 1981; 10(3):189-92. PubMed ID: 7291952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene Fiale) and pharmaceutical products frequently used for combined therapy.
    Anacardio R; Perilli O; Bartolini S; Gentile MM; Mazzeo P; Carlucci G
    Boll Chim Farm; 2002; 141(2):122-7. PubMed ID: 12135160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and tolerability of ketoprofen lysine salt foam for topical use in the treatment of traumatic pathologies of the locomotor apparatus].
    Parrini M; Cabitza P; Arrigo A; Vanasia M
    Clin Ter; 1992 Sep; 141(9):199-204. PubMed ID: 1458806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of ketoprofen in patients with renal failure].
    Stafanger G; Larsen HW; Hansen H; Serensen K
    Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release.
    Del Gaudio P; Russo P; Rosaria Lauro M; Colombo P; Aquino RP
    AAPS PharmSciTech; 2009; 10(4):1178-85. PubMed ID: 19856108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of indomethacin from a modified release system containing indomethacin as the lysine salt.
    Marzo A; Reiner A; Arrigoni Martelli E; Conte U; Colombo P; La Manna A
    Eur J Clin Pharmacol; 1987; 32(1):85-7. PubMed ID: 3108010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of ketoprofen lysine salt (artrosilene) in the treatment of nonspecific vertebrogenic pain syndromes in outpatients].
    Trubetskaia EA; Boĭko AN; Khozova A; Kamchatnov PR; Petrov SV; Otcheskaia OV; Gandzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):53-5. PubMed ID: 23528496
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of probenecid on ketoprofen kinetics.
    Upton RA; Williams RL; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1982 Jun; 31(6):705-12. PubMed ID: 7075118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.